Spyre Therapeutics stock falls on public offering launch
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| (NASDAQ: SYRE) | Delayed: 92.72 -0.47 (0.5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $93.19 | 52 Week High | $ | |||
| Open | $93.02 | 52 Week Low | $ | |||
| Day High | $95.01 | P/E | N/A | |||
| Day Low | $89.49 | EPS | $ | |||
| Volume | 642,764 | |||||
